Mankind Pharma Approves Rs 10,000 Cr Fundraising
By Rediff Money Desk, New Delhi Sep 30, 2024 17:18
Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The company will utilize the funds for growth and expansion.
New Delhi, Sep 30 (PTI) Mankind Pharma on Monday said it will raise up to Rs 10,000 crore via issuance of non-convertible debentures and commercial papers.
The company said its board has approved to raise up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months.
The board's fundraising committee also approved to raise up to Rs 5,000 crore via listed and rated commercial papers, having face value as may be decided in accordance with applicable law, in one or more tranches or series, the drug maker said in a regulatory filing.
The company, however, did not disclose how it aims to utilise the raised capital.
In July this year, Mankind had announced the acquisition of Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
Shares of the company on Monday ended 2.68 per cent down at Rs 2,521.55 apiece on BSE.
The company said its board has approved to raise up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months.
The board's fundraising committee also approved to raise up to Rs 5,000 crore via listed and rated commercial papers, having face value as may be decided in accordance with applicable law, in one or more tranches or series, the drug maker said in a regulatory filing.
The company, however, did not disclose how it aims to utilise the raised capital.
In July this year, Mankind had announced the acquisition of Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
Shares of the company on Monday ended 2.68 per cent down at Rs 2,521.55 apiece on BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.41 ( -4.74)
- 91845255
- Spicejet Ltd.
- 63.70 (+ 7.98)
- 83328500
- Standard Capital
- 1.67 (+ 9.87)
- 77646230
- Reliance Power L
- 48.67 (+ 4.98)
- 37099881
- Vodafone Idea L
- 10.36 ( -2.91)
- 34631406
MORE NEWS
Sebi Fines NSE Data And Analytics Rs 12 Lakh -...
SEBI has imposed a Rs 12 lakh fine on NSE Data And Analytics Ltd for failing to...
Airtel Prepays Rs 8,465 Cr for 2016 Spectrum
Bharti Airtel prepays Rs 8,465 crore to the government for spectrum acquired in 2016,...
States Push for Employment Data, Focused Job...
Several Indian states advocate for creating employment data and adopting a targeted...